Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia--13-year study

scientific article published on January 1983

Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia--13-year study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0021-9681(83)90169-8
P8608Fatcat IDrelease_4jfyf7p5jzfl7advmpi2kacdqy
P698PubMed publication ID6853663

P2093author name stringStenhouse NS
Cullen K
Wearne KL
Welborn TA
P433issue5
P921main subjectAustraliaQ408
regression analysisQ208042
cardiovascular diseaseQ389735
P304page(s)371-377
P577publication date1983-01-01
P1433published inJournal of Chronic DiseasesQ24039134
P1476titleMultiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia--13-year study
P478volume36

Reverse relations

cites work (P2860)
Q41486308Cardiovascular risk factors in women
Q50570829Changes in lung function determined longitudinally compared with decline assessed cross-sectionally. The Cracow Study.
Q35558834Decline in lung function and mortality: the Busselton Health Study
Q46189800Decreased glucose tolerance, not decreased insulin sensitivity, is a maturational abnormality in the male offspring of a parent with early coronary artery disease
Q41457652Determinants of coronary vascular disease in patients with type II diabetes mellitus and their therapeutic implications.
Q37934887Dyslipoproteinemia and diabetes.
Q68219411Elevated serum uric acid--a facet of hyperinsulinaemia
Q43573713Evaluation of features of syndrome X in offspring of Caribbean patients with Type 2 diabetes
Q44636477Haemoglobin predicts total mortality in a general young and middle-aged male population. The Tromsø Study
Q42554965Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients
Q38524435Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
Q51594002Impaired glucose and insulin metabolism in borderline hypertension.
Q69899886Insulin and atheroma
Q33612890Insulin and atherosclerosis: villain, accomplice, or innocent bystander?
Q45402227Insulin and cardiovascular disease: biomarker or association?
Q41718753Insulin and coronary artery disease: is syndrome X the unifying hypothesis?
Q41333286Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study
Q39637369Is insulin atherogenic?
Q70211005Is insulin atherogenic?
Q35366993Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies.
Q33702283Ischaemic heart disease: association with haematocrit in the British Regional Heart Study
Q54122646Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
Q47252432Low density lipoprotein particle size and risk factors of insulin resistance syndrome
Q61696438Lung Function, Respiratory Symptoms, and Mortality
Q33707117Meta-analysis of the effect of excluding early deaths on the estimated relationship between body mass index and mortality
Q40572164Obesity, lipids, cardiovascular risk, and androgen excess
Q70557859Periodic health examination, 1993 update: 2. Lowering the blood total cholesterol level to prevent coronary heart disease. Canadian Task Force on the Periodic Health Examination
Q69757074Polycythaemia study. A project of the Royal College of Physicians Research Unit. 1. Objectives, background and design
Q40402972Prognosis of risk factors and trends in mortality from external causes among middle-aged men in Lithuania
Q39750549Psychosocial aspects of coronary heart disease
Q50003699Pulmonary Impairment and Risk Assessment in a Diacetyl-exposed Population: Microwave Popcorn Workers
Q43575863Random fasting hyperglycemia as cardiovascular risk factor in the elderly: a 6-year longitudinal study.
Q30446141Rationale, design and methods for a community-based study of clustering and cumulative effects of chronic disease processes and their effects on ageing: the Busselton healthy ageing study.
Q40812889Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal
Q37207656Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2
Q68310158The 25 year estimated probability of death from some specific causes as a function of twelve risk factors in middle aged men
Q33704724The adverse health effects of tobacco and tobacco-related products
Q50954640Up-regulation of IGF binding protein-1 as an anticarcinogenic strategy: relevance to caloric restriction, exercise, and insulin sensitivity.
Q40560106Why is insulin not a risk factor for coronary heart disease?

Search more.